These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26077607)

  • 1. Regulatory T lymphocytes and transforming growth factor beta in epithelial ovarian tumors-prognostic significance.
    Winkler I; Wilczynska B; Bojarska-Junak A; Gogacz M; Adamiak A; Postawski K; Darmochwal-Kolarz D; Rechberger T; Tabarkiewicz J
    J Ovarian Res; 2015 Jun; 8():39. PubMed ID: 26077607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FoxP3+ regulatory T cells in peripheral blood of patients with epithelial ovarian cancer.
    Erfani N; Hamedi-Shahraki M; Rezaeifard S; Haghshenas M; Rasouli M; Samsami Dehaghani A
    Iran J Immunol; 2014 Jun; 11(2):105-12. PubMed ID: 24975967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Th17 lymphocytes and cytokine IL‑17A in epithelial ovarian tumors.
    Winkler I; Pyszniak M; Pogoda K; Semczuk A; Gogacz M; Miotla P; Adamiak A; Darmochwal-Kolarz D; Rechberger T; Tabarkiewicz J
    Oncol Rep; 2017 May; 37(5):3107-3115. PubMed ID: 28393233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association of Peripheral Blood Regulatory T-Cell Concentrations With Epithelial Ovarian Cancer: A Brief Report.
    Cannioto RA; Sucheston-Campbell LE; Hampras S; Goode EL; Knutson K; Ness R; Modugno F; Wallace P; Szender JB; Mayor P; Hong CC; Joseph JM; Friel G; Davis W; Nesline M; Eng KH; Edwards RP; Kruszka B; Schmitt K; Odunsi K; Moysich KB
    Int J Gynecol Cancer; 2017 Jan; 27(1):11-16. PubMed ID: 27759594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
    Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between Treg cells and tumor-associated macrophages in the tumor microenvironment of epithelial ovarian cancer.
    Zhu Q; Wu X; Wu Y; Wang X
    Oncol Rep; 2016 Dec; 36(6):3472-3478. PubMed ID: 27748885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Treg cells and IDO on human epithelial ovarian cancer cells under hypoxic conditions.
    Liu J; Zhang H; Jia L; Sun H
    Mol Med Rep; 2015 Mar; 11(3):1708-14. PubMed ID: 25376937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer.
    Knutson KL; Maurer MJ; Preston CC; Moysich KB; Goergen K; Hawthorne KM; Cunningham JM; Odunsi K; Hartmann LC; Kalli KR; Oberg AL; Goode EL
    Cancer Immunol Immunother; 2015 Dec; 64(12):1495-504. PubMed ID: 26298430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment.
    Zhang S; Ke X; Zeng S; Wu M; Lou J; Wu L; Huang P; Huang L; Wang F; Pan S
    Cell Mol Immunol; 2015 Sep; 12(5):580-91. PubMed ID: 26166762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-200a expression in CD4+ T cells correlates with the expression of Th17/Treg cells and relevant cytokines in psoriasis vulgaris: A case control study.
    Wang XY; Chen XY; Li J; Zhang HY; Liu J; Sun LD
    Biomed Pharmacother; 2017 Sep; 93():1158-1164. PubMed ID: 28738533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency, suppressive capacity, recruitment and induction mechanisms of regulatory T cells in sinonasal squamous cell carcinoma and nasal inverted papilloma.
    Lou H; Fang J; Li P; Zhou W; Wang Y; Fan E; Li Y; Wang H; Liu Z; Xiao L; Wang C; Zhang L
    PLoS One; 2015; 10(5):e0126463. PubMed ID: 26020249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-infiltrating cytotoxic T lymphocytes as independent prognostic factor in epithelial ovarian cancer with wilms tumor protein 1 overexpression.
    Vermeij R; de Bock GH; Leffers N; Ten Hoor KA; Schulze U; Hollema H; van der Burg SH; van der Zee AG; Daemen T; Nijman HW
    J Immunother; 2011; 34(6):516-23. PubMed ID: 21654520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune regulatory cells and IL17-producing lymphocytes in patients with benign and malignant salivary gland tumors.
    Haghshenas MR; Khademi B; Faghih Z; Ghaderi A; Erfani N
    Immunol Lett; 2015 Apr; 164(2):109-16. PubMed ID: 25739075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose splenic radiation inhibits liver tumor development of rats through functional changes in CD4+CD25+Treg cells.
    Wang B; Li B; Dai Z; Ren S; Bai M; Wang Z; Li Z; Lin S; Wang Z; Huang N; Yang P; Liu M; Min W; Ma H
    Int J Biochem Cell Biol; 2014 Oct; 55():98-108. PubMed ID: 25168696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher Numbers of T-Bet+ Tumor-Infiltrating Lymphocytes Associate with Better Survival in Human Epithelial Ovarian Cancer.
    Xu Y; Chen L; Xu B; Xiong Y; Yang M; Rui X; Shi L; Wu C; Jiang J; Lu B
    Cell Physiol Biochem; 2017; 41(2):475-483. PubMed ID: 28214872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4
    Kindlund B; Sjöling Å; Yakkala C; Adamsson J; Janzon A; Hansson LE; Hermansson M; Janson P; Winqvist O; Lundin SB
    Gastric Cancer; 2017 Jan; 20(1):116-125. PubMed ID: 26782287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Th17 and CD4
    Xiang M; Guo L; Ma Y; Li Y
    Pak J Pharm Sci; 2016 Nov; 29(6 Suppl):2405-2410. PubMed ID: 28167485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular Endothelial Growth Factor (VEGF) Polymorphisms and Serum VEGF Levels in Women With Epithelial Ovarian Cancer, Benign Tumors, and Healthy Ovaries.
    González-Palomares B; Coronado Martín PJ; Maestro de Las Casas ML; Veganzones de Castro S; Rafael Fernández S; Vidaurreta Lázaro M; De la Orden García V; Vidart Aragon JA
    Int J Gynecol Cancer; 2017 Jul; 27(6):1088-1095. PubMed ID: 28574932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.
    Hampras SS; Sucheston-Campbell LE; Cannioto R; Chang-Claude J; Modugno F; Dörk T; Hillemanns P; Preus L; Knutson KL; Wallace PK; Hong CC; Friel G; Davis W; Nesline M; Pearce CL; Kelemen LE; Goodman MT; Bandera EV; Terry KL; Schoof N; Eng KH; Clay A; Singh PK; Joseph JM; Aben KK; Anton-Culver H; Antonenkova N; Baker H; Bean Y; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bruinsma F; Butzow R; Campbell IG; Carty K; Cook LS; Cramer DW; Cybulski C; Dansonka-Mieszkowska A; Dennis J; Despierre E; Dicks E; Doherty JA; du Bois A; Dürst M; Easton D; Eccles D; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Gronwald J; Harrington P; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MA; Hogdall C; Hogdall E; Hosono S; Iversen ES; Jakubowska A; Jensen A; Ji BT; Karlan BY; Kellar M; Kelley JL; Kiemeney LA; Klapdor R; Kolomeyevskaya N; Krakstad C; Kjaer SK; Kruszka B; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lissowska J; Liu S; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Moes-Sosnowska J; Narod SA; Nedergaard L; Nevanlinna H; Nickels S; Olson SH; Orlow I; Weber RP; Paul J; Pejovic T; Pelttari LM; Perkins B; Permuth-Wey J; Pike MC; Plisiecka-Halasa J; Poole EM; Risch HA; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schernhammer E; Schmitt K; Schwaab I; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Tangen IL; Teo SH; Thompson PJ; Timorek A; Tsai YY; Tworoger SS; Tyrer J; van Altena AM; Vergote I; Vierkant RA; Walsh C; Wang-Gohrke S; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Wu AH; Wu X; Woo YL; Yang H; Zheng W; Ziogas A; Gayther SA; Ramus SJ; Sellers TA; Schildkraut JM; Phelan CM; Berchuck A; Chenevix-Trench G; Cunningham JM; Pharoah PP; Ness RB; Odunsi K; Goode EL; Moysich KB
    Oncotarget; 2016 Oct; 7(43):69097-69110. PubMed ID: 27533245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytidine monophosphate kinase is inhibited by the TGF-β signalling pathway through the upregulation of miR-130b-3p in human epithelial ovarian cancer.
    Zhou D; Zhang L; Sun W; Guan W; Lin Q; Ren W; Zhang J; Xu G
    Cell Signal; 2017 Jul; 35():197-207. PubMed ID: 28414100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.